ASHLEY L LEGRAND ROZOVICS
Allopathic & Osteopathic Physicians|Family Medicine OMAHA, NE NPI 1386900538
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine NE ABBVIE INC. All categories
General Payments — all program years on this page
$7,050.79
- Category: General Payments
- Program years: PY2018–2024
- Record count: 495
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,212.07 across 77 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,212.07 | 77 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $432.84 | 30 |
| Abbott Laboratories | $63.83 | 3 |
| Novo Nordisk AS | $62.46 | 4 |
| Janssen Pharmaceuticals, Inc | $60.84 | 4 |
| PFIZER INC. | $57.11 | 3 |
| Lilly USA, LLC | $48.83 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $45.65 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $38.46 | 2 |
| Almatica Pharma Inc. | $37.49 | 2 |
| Azurity Pharmaceuticals, Inc. | $33.12 | 2 |
| Gilead Sciences, Inc. | $31.25 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $31.05 | 2 |
| Otsuka America Pharmaceutical, Inc. | $30.09 | 2 |
| Acerta Pharma LLC | $29.79 | 2 |
| Amgen Inc. | $28.12 | 2 |
| Astellas Pharma US Inc | $26.91 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.75 | 2 |
| Exact Sciences Corporation | $23.23 | 1 |
| Kyowa Kirin, Inc. | $19.73 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $16.88 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $14.80 | 1 |
| Lexicon Pharmaceuticals, Inc. | $14.28 | 1 |
| SANOFI PASTEUR INC. | $14.21 | 1 |
| Ardelyx, Inc. | $13.98 | 1 |
| Corium, Inc. | $10.37 | 1 |
By program year
Records — PY2024 (77)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.